Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer’s Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells. The gene discussed is LGMN; the disease is early-onset autosomal dominant Alzheimer disease.